MLTX
NASDAQ · Biotechnology
Moonlake Immunotherapeutics
$11.53
+0.73 (+6.76%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
-8.6% upside
Low Target
$8.06
Average Target
$10.54
High Target
$16.98
Current Price
$11.53
Current
$11.53
$11.53
Target
$10.54
$10.54
$8.06
$10.54 avg
$16.98
Scenario Analysis
Bear Case
$8.06
-30.1%
Low target
Base Case
$10.54
-8.6%
Avg target
Bull Case
$16.98
+47.3%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$23.29
-50.5% from high
52-Week Low
$9.46
+21.9% from low
Target vs 52W High
$10.54
-54.7% vs high
Next Earnings Report
Nov 17, 2026 · Before Market Open
6d
until earnings
EPS Est: $-0.80
Earnings in 6 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.2% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.2% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.4% |
| MRNA | Hold | 31 | 32% | $149.45 | -44.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.7% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.4% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -43.0% |